Summary
The effect of nicotinic acid and pentaerythritoltetranicotinate (Perycit®, Bofors) on cardiac output, FFA-level and content of free nicotinic acid in plasma was studied in healthy humans —. Nicotinic acid infused intravenously in a dose of 0.05 mg/kg/min for 180 min or administered orally in a dose of 1 g increased the cardiac output maximally by about 20 per cent for 30–60 min. The total peripheral resistance decreased and the pulse rate and stroke volume increased moderately. Pentaerythritoltetranicotinate produced the same effects but the increase of cardiac output lasted longer. In all series there was a considerable decrease of the FFA-level of plasma. The increase of the plasma concentration of nicotinic acid was most pronounced after 1 g of nicotinic acid administered orally. The effect on the cardiac output was greatest the longer the plasma concentration of nicotinic acid increased.
Similar content being viewed by others
References
Aberg, G., Dzedin, T., Lundholm, L., Olsson, L., Svedmyr, N.: A comparative study of some cardiovascular effects of sotalol (MJ 1999) and propranolol. Life Sci. (In press).
— — — — — Influence of sotalol (MJ 1999) and propranolol on some metabolic actions of adrenaline in the rabbit. Acta pharmacol. (In press).
Blinks, J. R.: Evaluation of the cardiac effects of several adrenergic blocking agents. Ann. N.Y. Acad. Sci. 139, 673–685 (1962).
Hamer, J., Sowton, E.: Cardiac output after β-adrenergic blockade in ischaemic heart disease. Brit. Heart. J. 27, 892–897 (1965).
Hoffman, R.P., Grupp, G.: The effects of sotalol and propranolol on contractile force and atrioventricular conduction time of the dog heart in situ. Dis. Chest 55, 229–234 (1969).
Lish, P. M., Weikel, J. H., Dungan, K. W.: Pharmacological and toxicological properties of two new β-adrenergie receptor antagonists. J. Pharmacol. exp. Ther. 149, 161–173 (1965).
Puri, P. S., Bing R. J.: Effects on myocardial contractility, hemodynamics and cardiac metabolism of a new adrenergic blocking drug, sotalol. Dis. Chest 55, 235–239 (1969).
Stanton, H. C., Kirchgessner, T., Parmenter, K.: Cardiovascular pharmacology of two new β-adrenergic receptor antagonists. J. Pharmacol. exp. Ther. 149, 174–182 (1965).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ekström-Jodal, B., Harthon, L., Häggendal, E. et al. Influence of nicotinic acid and pentaerythritoltetranicotinate (Perycit®, Bofors) on the cardiac output in man. Pharmacol. Clin. 2, 86–89 (1970). https://doi.org/10.1007/BF00420712
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00420712